文献速递妇产影像技术与安全US

低强度脉冲超声促进产后子宫复旧的前瞻性多中心研究

Low-intensity pulsed ultrasound to facilitate uterine involution: prospective multicenter study on clinical efficacy and mechanistic insights.
PubMed 文献 · Ultrasound Obstet Gynecol · 2026-09-27

该研究为多中心、随机、双盲、对照试验,评估低强度脉冲超声(LIPUS)对产后子宫复旧的临床疗效与安全性,并结合动物和细胞实验探讨机制。结果显示,LIPUS组产后第10天子宫体积缩小更显著,产后并发症发生率更低。机制可能与增强平滑肌细胞钙内流及上调内皮素-1和催产素受体表达有关。

要点

  • LIPUS组子宫体积缩小率、宫底下降指数均优于对照组,恶露时间更短。
  • LIPUS组继发性产后出血和产褥感染发生率均低于对照组。
  • 机制涉及L型钙通道介导的钙内流增加及ET-1、OTR表达上调。

核心结论

  • LIPUS可显著降低产后子宫体积并减少产后并发症,提示其可能促进子宫复旧。
  • LIPUS的作用可能通过增强子宫平滑肌细胞钙内流及上调ET-1和OTR表达来实现。

研究设计与样本

  • 多中心、随机、双盲、对照试验,2023年1月至2024年12月在中国三个中心开展。
  • 共纳入1106名参与者,LIPUS组553名、对照组553名,最终分析各528名和530名。
  • LIPUS参数:0.8 MHz,空间峰值时间平均强度2.0 W/cm²,焦点面积0.09–0.12 cm²,脉宽4 ms。
  • 产后2小时开始治疗,每日30分钟,连续10天;对照组采用相同参数但无声输出的假治疗。
  • 主要结局为产后第10天经腹三维超声测量的子宫体积缩小率。

关键影像表现/征象

  • 经腹三维超声显示LIPUS组产后第10天子宫体积缩小率显著大于对照组。
  • LIPUS组宫底下降指数和子宫径线指标优于对照组。

诊断标准与关键数值

  • 主要结局为产后第10天经腹三维超声测量的子宫体积缩小率,LIPUS组显著优于对照组(P<0.05)。
  • 次要结局中,LIPUS组继发性产后出血和产褥感染发生率显著低于对照组(P<0.05)。
  • 次要结局中,LIPUS组恶露持续时间显著短于对照组(P<0.05)。
  • 体外实验中,LIPUS显著增加大鼠子宫组织条收缩力和子宫平滑肌细胞细胞内Ca²⁺水平(P<0.001)。
  • LIPUS处理的大鼠子宫组织和子宫平滑肌细胞中ET-1和OTR表达均显著高于对照组(P<0.05)。

临床应用与阅片要点

  • 产后可考虑将低强度脉冲超声作为促进子宫复旧的无创辅助手段。
  • 临床随访中可用经腹三维超声测量子宫体积缩小率来客观评价子宫复旧效果。
  • 需注意LIPUS的作用机制涉及L型钙通道,联合使用钙通道阻滞剂时可能影响疗效。

局限性

  • 原文未报告研究本身的局限性相关信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To assess the clinical efficacy and safety of low-intensity pulsed ultrasound (LIPUS) in facilitating uterine involution after delivery and mitigating postpartum complications, and to explore its molecular mechanisms of action through both in-vitro and in-vivo experimental animal models.

METHODS: This multicenter, randomized, double-blind, controlled trial was conducted across three centers in China from January 2023 to December 2024. Participants were randomized to a LIPUS group or a control group. The LIPUS group received treatment at 0.8 MHz with a spatial peak-temporal average intensity of 2.0 W/cm2, focal area of 0.09-0.12 cm2 and pulse duration of 4 ms, for 30 min daily over 10 consecutive days, starting 2 h after delivery. The control group received sham treatment with identical parameters but no acoustic output. The primary outcome, percentage reduction in uterine volume on post-treatment day 10, measured using transabdominal three-dimensional ultrasonography, was compared between the two groups. Secondary outcomes, including the incidence of postpartum complications (secondary postpartum hemorrhage and puerperal infection), duration of lochia and indices of uterine involution (fundal height descent index and uterine dimensions) were also compared. For in-vivo experiments, uterine tissues from postpartum Sprague-Dawley rats that had undergone LIPUS or sham treatment were evaluated using hematoxylin and eosin staining for morphology, and immunohistochemistry and Western blotting to assess distribution of endothelin-1 (ET-1) and oxytocin receptor (OTR) proteins and to quantify their expression. For in-vitro experiments, uterine tissue strips from untreated rats were exposed to LIPUS or sham treatment ex vivo for contractility measurement using a BL-420F biological signal acquisition system. Primary uterine smooth-muscle cells (USMCs) from untreated rats were exposed to LIPUS or sham irradiation in vitro and assessed for intracellular calcium ions (Ca2+) by fluorescence imaging and flow cytometry, and for ET-1 and OTR expression by Western blotting. To assess calcium-channel involvement, nifedipine (an L-type calcium-channel antagonist) was included in the contractility and flow cytometry experiments, establishing four treatment groups: control, LIPUS alone, nifedipine alone and LIPUS + nifedipine. For in-vivo and in-vitro experiments, results were compared between the LIPUS-treated and control groups; for the contractility and flow cytometry assays, comparisons were made among all four groups.

RESULTS: In total, 1106 participants were enrolled, with 553 assigned randomly to the control group and 553 to the LIPUS group. After exclusions, 528 women in the LIPUS group and 530 in the control group were included in the final analysis. Compared with controls, the LIPUS-treated participants showed a significantly greater percentage reduction in uterine volume and fundal height descent index, shorter lochia duration, reduced uterine dimensions and a lower incidence of secondary postpartum hemorrhage and puerperal infection (all P < 0.05). In-vitro experiments demonstrated that LIPUS was significantly associated with increased contractility of rat uterine tissue strips and elevated intracellular Ca2+ levels in USMCs (P < 0.001); these effects were attenuated by nifedipine but partially restored by LIPUS. Expression levels of ET-1 and OTR were also significantly higher in LIPUS-treated uterine tissue and USMCs compared with controls (P < 0.05).

CONCLUSIONS: LIPUS application is significantly associated with reduced uterine volume and fewer postpartum complications, suggesting its potential to promote uterine involution. This effect may be mediated through enhanced Ca2+ influx and upregulation of ET-1 and OTR in USMCs. These findings support the potential of LIPUS as a non-invasive approach to improve postpartum outcomes. © 2026 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Liu, Xie, Wang, et al. Low-intensity pulsed ultrasound to facilitate uterine involution: prospective multicenter study on clinical efficacy and mechanistic insights. Ultrasound Obstet Gynecol. 2026. PMID: 42802640. doi:10.1002/uog.70330

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。